Uncommon lineage switch warrants immunophenotyping even in relapsing leukemia

Leukemia Research

Volumn 33, Issue 7, 2009, Pages

  van den Ancker, Willemijn ^a   Terwijn, Monique ^a   Regelink, Josien ^a   Westers, Theresia M ^a   Ossenkoppele, Gert J ^a   Loosdrecht, Arjan A van de ^a   Zweegman, Sonja ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CD56 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; HEMOGLOBIN; LACTATE DEHYDROGENASE; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; MICROSOMAL AMINOPEPTIDASE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; BLAST CELL; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER RELAPSE; CASE REPORT; DRUG MEGADOSE; FEVER; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOPHENOTYPING; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; LEUKOCYTE COUNT; LUMBAR PUNCTURE; MALE; MICROSCOPY; NIGHT SWEAT; PANCYTOPENIA; PARONYCHIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE COUNT; TRISOMY; WEIGHT REDUCTION;

ADULT; ANTIGENS, CD; CELL LINEAGE; CYTOGENETIC ANALYSIS; FATAL OUTCOME; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MALE; NEOPLASM RECURRENCE, LOCAL; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; YOUNG ADULT;

EID: 67349114811     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.11.029     Document Type: Letter

References (23)

1. Pui C.H., Robison L.L., and Look A.T. Acute lymphoblastic leukaemia. Lancet 371 9617 (2008) 1030-1043
2. Andersson A., Ritz C., Lindgren D., Eden P., Lassen C., Heldrup J., et al. Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status. Leukemia 21 6 (2007) 1198-1203
3. Winick N.J., McKenna R.W., Shuster J.J., Schneider N.R., Borowitz M.J., Bowman W.P., et al. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. J Clin Oncol 11 2 (1993) 209-217
4. Seedhouse C., and Russell N. Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia. Br J Haematol 137 6 (2007) 513-529
5. Gagnon G.A., Childs C.C., LeMaistre A., Keating M., Cork A., Trujillo J.M., et al. Molecular heterogeneity in acute leukemia lineage switch. Blood 74 6 (1989) 2088-2095
6. van der Velden V., van L.K., Hoogeveen P.G., Beverloo H.B., and Breems D.A. Unusual immunophenotypic shift in a patient with T-cell acute lymphoblastic leukemia. Leukemia 20 9 (2006) 1626-1629
7. Matsuda I., Nakamaki T., Amaya H., Kiyosaki M., Kawakami K., Yamada K., et al. Acute myeloid leukemia originating from the same leukemia clone after the complete remission of acute lymphoid leukemia. Rinsho Ketsueki 44 9 (2003) 946-951
8. Hershfield M.S., Kurtzberg J., Harden E., Moore J.O., Whang-Peng J., and Haynes B.F. Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2′-deoxycoformycin. Proc Natl Acad Sci USA 81 1 (1984) 253-257
9. Saso R., Zomas A., Hamblin M., Dunlop L., Swansbury G.J., Min T., et al. Sequential development of myelodysplasia and acute myeloid leukemia but with no karyotypic evolution after autografting in a patient with Philadelphia positive acute lymphoblastic leukemia. Leuk Lymphoma 26 5-6 (1997) 625-628
10. Mantadakis E., Danilatou V., Stiakaki E., Paterakis G., Papadhimitriou S., and Kalmanti M. T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia. Pediatr Blood Cancer 48 3 (2007) 354-357
11. Thomas DA, O'Brien S, Jorgensen JL, Cortes J, Faderl S, Garcia-Manero G, et al. Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia. Blood 2008; doi:10.1182/blood-2008-04-151860.
12. Castillo J., Winer E., and Quesenberry P. Newer monoclonal antibodies for hematological malignancies. Exp Hematol 36 7 (2008) 755-768
13. Bug G., Atta J., Klein S.A., Hertenstein B., Bergmann L., Boehrer S., et al. High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous stem cell transplantation. Ann Hematol 84 11 (2005) 748-754
14. Hashimoto S., Toba K., Aoki S., Tsuchiyama J., Tsukada N., Takahashi H., et al. Acute T-lymphoblastic leukemia relapsed with the character of myeloid/natural killer cell precursor phenotype: a case report. Leuk Res 26 2 (2002) 215-219
15. Ihle R., Matthes H., and Ihle H. Phenotype switch in acute leukemia patients after intensive chemotherapy. Haematol Blood Transfus 32 (1989) 101-103
16. Pane F., Frigeri F., Camera A., Sindona M., Brighel F., Martinelli V., et al. Complete phenotypic and genotypic lineage switch in a Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia 10 4 (1996) 741-745
17. Stass S., Mirro J., Melvin S., Pui C.H., Murphy S.B., and Williams D. Lineage switch in acute leukemia. Blood 64 3 (1984) 701-706
18. Kurtzberg J., Denning S.M., Nycum L.M., Singer K.H., and Haynes B.F. Immature human thymocytes can be driven to differentiate into nonlymphoid lineages by cytokines from thymic epithelial cells. Proc Natl Acad Sci USA 86 19 (1989) 7575-7579
19. - leukemia: usefulness of cytoplasmic antigen detection for subclassification. Leukemia 7 11 (1993) 1759-1765
20. Bell J.J., and Bhandoola A. The earliest thymic progenitors for T cells possess myeloid lineage potential. Nature 452 7188 (2008) 764-767
21. Wada H., Masuda K., Satoh R., Kakugawa K., Ikawa T., Katsura Y., et al. Adult T-cell progenitors retain myeloid potential. Nature 452 7188 (2008) 768-772
22. Weerkamp F., Baert M.R., Brugman M.H., Dik W.A., de Haas E.F., Visser T.P., et al. Human thymus contains multipotent progenitors with T/B lymphoid, myeloid, and erythroid lineage potential. Blood 107 8 (2006) 3131-3137
23. -) phenotype. Am J Hematol 40 2 (1992) 98-102